POST
I’ve deleted my stock broker app
To avoid the panic selling I’m gonna wait for a week. Screenshot on last Friday market opening
- Total posts
- 557
- Total predictions
- 221
- Success rate
- 49.8%
- Avg score
- 0.13
POST
POST
0 DTE SPX Iron Condor Yolo
https://preview.redd.it/mk8pchmf4yge1.png?width=1434&format=png&auto=webp&s=af3dd4d5d0c0f6e4068a3770fe86641ec7aa2add I will never trade iron condors on my shitty Canadian brokerage app again. They can't even allow me to put it in as one trade.
TARG
$123,000 of HON stock going into earnings (100% of life savings)
Diversification is when you have calls of different strikes right??? I decided to be a lame boring loser and sold most of my long calls for shares, but upped my short calls. Going into earnings, $3200 or so in calls, …
POST
Brilliant or completely regarded?
Ported what was left in my cash account into NVDA today. Down about 60k in this account, hoping to make some of that back
POST
BUY
$10,000+ YOLO LLY PLAY (EARNINGS SOON)
Hello fellow traders, This is my $10k+ position into THE MOTHER OF WEGOVY! The reason why I’m so bullish is due to RFKs recent comment on wegovy and ozempic being miracle drugs and having earnings soon with possibly great guidance. …
Score0.12
View →
POST
POST
Part 3: $10k -> $195k -> $400k -> $600k in 5 trading sessions
Here's the continuation of my SPY 0DTE plays in less than a week starting from $10k. All **realized** gains. Today I probably left $100k on the table (maybe more, depending on how SPY closes), but nevertheless good enough performance in …
STRO
MNMD $10k YOLO into short dated options
https://preview.redd.it/3sa31ovsizge1.jpg?width=1179&format=pjpg&auto=webp&s=ffa8b3b577b77c0e6ec79c30f4e23e034ceddcd2 My reasoning? Mindmed received a fast track status on their first phase 3 drug treatment to treat anxiety. This was pretty groundbreaking as its the first of its kind. [https://ir.mindmed.co/news-events/press-releases/detail/137/mindmed-receives-fda-breakthrough-therapy-designation-and-announces-positive-12-week-durability-data-from-phase-2b-study-of-mm120-for-generalized-anxiety-disorder](https://ir.mindmed.co/news-events/press-releases/detail/137/mindmed-receives-fda-breakthrough-therapy-designation-and-announces-positive-12-week-durability-data-from-phase-2b-study-of-mm120-for-generalized-anxiety-disorder) There is a new drug in the pipeline by …
Score0.66
View →